fda warning compounding semaglutide september 2025 and Novo Nordisk Warn of GLP-1 Telehealth Take Down – What's Next? Compounded' weight-loss drugs are a

However, once you achieve your goal, you and your provider may discuss tapering off the medication

Lilly does not promote or encourage use of any Lilly medicine outside of its FDA-approved indication. GLP-1 drugs and binge eating While some people with disordered eating over-restrict, others can binge to deal with stress or difficult emotions

Constipation Management During Wegovy Treatment: What to Do Managing constipation during Wegovy treatment is essential for maintaining comfort and digestive health

A recent GLP-1 medicine sold as Mounjaro and Zepbound also works on a second target, the GIP receptor

Concerning cutaneous manifestations, specifically bullous pemphigoid, retrospective analysis of over 9,000 patients treated in Japan (20092017) associated it with DPP-IV inhibitors, particularly vildagliptin (Kawaguchi et al., 2019)

The typical treatment requires starting at a low dose and gradually increasing it every four weeks